Study reveals how specific nasal cells protect against COVID-19 in paediatric patients
The findings suggest why children tend to experience milder symptoms compared to older adults
Read Moreby Jen Brogan | Apr 17, 2024 | News | 0
The findings suggest why children tend to experience milder symptoms compared to older adults
Read Moreby Jen Brogan | Mar 1, 2024 | News | 0
Different factors, such as illness duration and virus variant, impacted patients cognitive abilities
Read Moreby Jen Brogan | Feb 8, 2024 | News | 0
The committee has advised that the vaccine should be given to those at the highest risk
Read Moreby Jen Brogan | Dec 11, 2023 | News | 0
New data highlights the inequalities in emergency hospital rates and vaccinations
Read Moreby Jen Brogan | Nov 20, 2023 | News | 0
The OpenSAFELY platform will support the discovery of new treatments
Read Moreby Jen Brogan | Nov 2, 2023 | News | 0
The NHS has already delivered over 20 million winter vaccines this year
Read Moreby Jen Brogan | Sep 18, 2023 | News | 0
The updated vaccines more closely target current circulating variants
Read Moreby Jen Brogan | Sep 14, 2023 | News | 0
The funding will reduce waiting lists and ease the demand on the NHS during Winter
Read Moreby Jen Brogan | Sep 14, 2023 | News | 0
The report highlights steps needed to ensure future pandemics are handled effectively
Read Moreby Emily Kimber | Aug 24, 2022 | News | 0
The phase 2/3 trial results showed that the vaccine was effective in protecting children
Read Moreby Lucy Parsons | Oct 11, 2021 | News | 0
‘Top-up’ doses of approved vaccines to be offered to ensure clinical trialists can travel abroad
Read Moreby Lucy Parsons | Sep 21, 2021 | News | 0
Ronapreve will be targeted at hospitalised patients who have not mounted an antibody response against COVID-19
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479